Gladstone NOW: The Campaign Join Us on the Journey ✕
1 - 15 of 132 Results Clear All
New York Times—Gladstone Investigator Lennart Mucke comments on the connection between epilepsy and dementia, noting that some dementia-like symptoms may be caused by epileptic activity and resolve with treatment. (Subscription required.)
Mucke Lab Alzheimer’s Disease Epilepsy Neurological Disease
Scientists from across the NOMIS community gathered in Switzerland for the inaugural NOMIS Fellows Symposium.
NOMIS Neurological Disease Mucke Lab
TIME—Gladstone Investigator Lennart Mucke provides crucial scientific context on new Alzheimer's clinical data dominating headlines, drawing on his lab’s pioneering discovery of tau’s role in disease.
Mucke Lab Alzheimer’s Disease Neurological Disease
TIME—Gladstone Investigator Lennart Mucke provides crucial scientific context on new Alzheimer’s clinical data dominating headlines, drawing on his lab’s pioneering discovery of tau’s therapeutic potential.
Mucke Lab Alzheimer’s Disease Neurological Disease
NOMIS–Gladstone Fellow Cathrine Sant is studying an enigmatic region of the human genome linked to neurodegenerative disease risk.
Neurological Disease NOMIS Graduate Students and Postdocs Profile
Alzforum—Gladstone Investigator Lennart Mucke commented on new research that sheds light on how changes in brain activity and the immune system may contribute to synapse loss in Alzheimer’s disease.
Alzheimer’s Disease Mucke Lab Neurological Disease
Nearly 20 years after his landmark study uncovered novel roles of tau in Alzheimer’s disease, Gladstone's Lennart Mucke shares his perspective on new clinical data that could transform the future of brain health.
Mucke Lab Alzheimer’s Disease Gladstone Experts Neurological Disease News Release
Gladstone scientists have developed a thinking microscope that can conduct its own experiments, with the ultimate goal of treating neurodegenerative diseases.
Finkbeiner Lab AI Center for Systems and Therapeutics Neurological Disease Alzheimer’s Disease Parkinson’s Disease ALS Huntington’s Disease
Gladstone scientists have developed a thinking microscope powered by artificial intelligence.
AI Finkbeiner Lab Neurological Disease Center for Systems and Therapeutics Alzheimer’s Disease Parkinson’s Disease ALS
The prize honors scientists whose breakthroughs in brain research have high potential for patient impact.
Philanthropy Awards News Release Alzheimer’s Disease Neurological Disease Yang Lab
Gladstone scientists developed a new tool to trace how the brain clears “waste,” uncovering surprising new biology about how it keeps itself healthy.
News Release Research (Publication) Alzheimer’s Disease Neurological Disease Yang Lab
The prize, issued annually to eight scientists, seeks to catalyze high-impact neuroscience research.
Awards News Release Alzheimer’s Disease Neurological Disease Corces Lab AI
Washington Post—Gladstone Investigator Lennart Mucke shares insights on the potential biological connections between two very different neurological conditions. (Subscription required.)
Mucke Lab Alzheimer’s Disease Neurological Disease
New findings on the APOE4 gene variant point to a potential therapeutic target for Alzheimer’s disease.
News Release Research (Publication) Alzheimer’s Disease Neurological Disease Huang Lab Aging Human Genetics
Scientists at Gladstone are combining AI models with cutting-edge lab tools to finally make sense of the human genome.
AI Srivastava Lab Pollard Lab Engelhardt Lab Theodoris Lab Shipman Lab Ramani Lab Finkbeiner Lab Cardiovascular Disease Neurological Disease
